XML 45 R22.htm IDEA: XBRL DOCUMENT

Fair Value Measurements and Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Cash Equivalents and Short-term Investments

The following is a summary of the Company’s cash equivalents and short-term investments (in thousands):


			December 31, 2023
			Amortized Cost Basis						Unrealized Gains						Unrealized Losses						Estimated Fair Value
Level 1
Money market funds			$	10,204					$	—					$	—					$	10,204
Level 2
Commercial paper			64,693						—						(35)						64,658
U.S. government and agency securities			17,616						4						(17)						17,603
Total cash equivalents and short-term investments			92,513						4						(52)						92,465
Less: Cash equivalents			(70,972)						—						33						(70,939)
Total short-term investments			$	21,541					$	4					$	(19)					$	21,526


			December 31, 2022
			Amortized Cost Basis						Unrealized Gains						Unrealized Losses						Estimated Fair Value
Level 1
Money market funds			$	10,235					$	—					$	—					$	10,235
Level 2
U.S. government and agency securities			59,487						—						(824)						58,663
Commercial paper			102,722						—						(246)						102,476
Corporate bonds			2,059						—						(35)						2,024
Total cash equivalents and short-term investments			174,503						—						(1,105)						173,398
Less: Cash equivalents			(56,256)						—						16						(56,240)
Total short-term investments			$	118,247					$	—					$	(1,089)					$	117,158